Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Grifols S.A. ADR (GRFS)

Grifols S.A. ADR (GRFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Grifols S.A. ADR 152-158 PARC DE NEGOCIS CAN SANT JOAN SANT CUGAT DEL VALLS BARCELONA U3 08174 ESP

www.grifols.com Employees: 23,822 P: 34-93-571-2200 F: +34 938008000

Sector:

Medical

Description:

Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.

Key Statistics

Overview:

Market Capitalization, $K 6,284,299
Enterprise Value, $K 16,225,499
Shares Outstanding, K 687,560
Annual Sales, $ 7,805 M
Annual Net Income, $ 169,800 K
Last Quarter Sales, $ 2,180 M
Last Quarter Net Income, $ 148,410 K
EBIT, $ 1,442 M
EBITDA, $ 1,916 M
60-Month Beta 0.67
% of Insider Shareholders 0.19%
% of Institutional Shareholders 0.00%
Float, K 686,254
% Float 99.81%
Short Interest 6,651
Short Float 0.00%
Short Volume Ratio 0.34

Growth:

1-Year Return 22.27%
3-Year Return -3.91%
5-Year Return -53.60%
5-Year Revenue Growth 36.67%
5-Year Earnings Growth -78.63%
5-Year Dividend Growth -100.00%

Per-Share Information:

Most Recent Earnings 0.19 on 07/28/25
Next Earnings Date 02/25/26
Earnings Per Share ttm 0.19
EPS Growth vs. Prev Qtr 9.75%
EPS Growth vs. Prev Year 850.00%
Annual Dividend & Yield 0.14 (1.55%)
Annual Dividend & Yield (Fwd) 0.14 (1.52%)
Most Recent Dividend 0.142 on 08/12/25
Next Ex-Dividends Date 08/12/25
Dividend Payable Date 08/20/25
Dividend Payout Ratio 73.71%
Most Recent Split 2-1 on 01/04/16

GRFS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 7.81
Price/Earnings to Growth 0.33
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 2.18%
Debt/Equity 1.28
Price/Sales 0.69
Price/Cash Flow 10.01
Price/Book 0.73
Book Value/Share 12.83
Interest Coverage -1.62

GRFS Dividends

Date Value
08/12/25 $0.1420
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar